Back to News
Market Impact: 0.25
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights
Source: PR Newswire
Legal & LitigationHealthcare & Biotech
DJS Law Group reminded investors of a securities class-action lawsuit against Capricor Therapeutics (NASDAQ: CAPR), alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act and Rule 10b-5. The notice signals litigation risk for the biotech company, though the excerpt provides no damages, alleged misconduct details, filing deadline, or financial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
CAPR-0.85
More News
- Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Lead Plaintiff Deadline on September 28, 2026
- SueWallSt Reminds Capricor Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026
- Kaplan Fox Reminds Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Securities Class Action Deadline - Contact the Firm Before September 28, 2026
- Bloomberg Law: No Breakup of Google & Clippers Fined (Podcast)
- Stock Movers: Chime, Stryker, Compass Pathways (Podcast)
- Cholesterol drug setback casts doubt over multibillion-dollar race